Dreux, M., Gastaminza, P., Wieland, S
BPC-157 lacks Health Canada approval, existing in a research chemical status where doctors cannot prescribe it
Instead, AOD-9604 mimics the metabolic benefits of hGH while reducing concerns over potential long-term side effects, such as insulin resistance or excessive tissue growth
It works best when injected directly at the injury site
Its required for the production of red blood cells, the maintenance of the myelin sheath that protects nerve fibers, and the synthesis of DNA
These findings support the rationale for frequent, low-dose supplementation strategies in healthy individuals, while also emphasising the need for personalised approaches in those with malabsorption syndromes (Bor et al., 2010)